On-demand webinar: A novel RNA polymerase variant for reduced dsRNA and simple IVT integration

This webinar explores how a novel RNA polymerase can help you reduce double-stranded RNA (dsRNA) byproducts during mRNA manufacturing, improving the tolerability, safety, and potency of potential mRNA therapies.

Key topics to be discovered:

Achieve dsRNA reduction by up to 85% in in vitro transcription (IVT)
Lower dsRNA levels in both mRNA and saRNA syntheses without impacting quality attributes
Integrate effortlessly into existing IVT protocols with simple enzyme substitution

Get access to the webinar and watch it anytime, anywhere

Complete the form below to get access to the webinar recording

On Demand Webinar: A novel RNA polymerase variant for reduced dsRNA and simple IVT integration

On Demand Webinar

Country Name

Country

Ship to State Name

Ship to State

Postal code

First Name

Last Name

Work Email

Phone number

Company/Institution

Job Title

Opt in

I would like to be connected to a sales specialist to learn about products and services to support my mRNA project.

Opt in

Yes, I would like to receive emails to stay informed about updates from TriLink Biotechnologies, including webinars, new product releases, and upcoming events.

TriLink BioTechnologies does not sell or distribute your information to 3rd parties. For more information, please refer to our Privacy Policy.

On-demand webinar: A novel RNA polymerase variant for reduced dsRNA and simple IVT integration

Key topics to be discovered:

Get access to the webinar and watch it anytime, anywhere

On Demand Webinar: A novel RNA polymerase variant for reduced dsRNA and simple IVT integration

The hottest topics and cutting-edge research—straight to your inbox.

Email Sign Up